Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study

Author(s):
Deodhar, A.; Braun, J.; Inman, R.D.; Heijde, D. van der; Zhou, Y.Y.; Xu, S.; Han, C.L.; Hsu, B.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-04-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2015), Vol. 74, no. 4, p. 757-761
hdl
1887/100335
doi
10.1136/annrheumdis-2014-205862